Alcon's recent upgrades and promising opportunities, including the BELKIN Vision acquisition, expanding glaucoma treatment ...

Oppenheimer has upgraded Alcon (NYSE:ALC) to outperform, citing multiple drivers. The investment bank said it sees several ...

Align Technology: The company delivered first-quarter fiscal 2024 adjusted earnings per share of $2.14, up 17.6% from the year-ago earnings. The bottom line beat the Zacks Consensus Estimate by 8.1%.

Q1 2024 Earnings Call Transcript May 14, 2024 Operator: Greetings, and welcome to the Alcon’s First Quarter 2024 Earnings Call. At this time, all participants are in a listen-only mode. A brief ...

Alcon posted adjusted earnings of 78 cents per share, beating market estimates of 73 cents per share. The company's quarterly ...

Shares of Alcon (NYSE:ALC) surged more than 9% in pre-market today after the eye care products manufacturer reported Q1 ...

According to Alcon, Surgical growth reflects strength in international markets. For the first quarter of 2024, Surgical net ...

Applied DNA Sciences, Inc. APDN -4.05% + Free Alerts shares dipped 8.2% to $2.83 in pre-market trading. Applied DNA Sciences ...

Alcon's strong revenue growth is attributed to successful product launches. Click here to read why I upgrade ALC stock from ...

By Adria Calatayud Alcon shares in Switzerland climbed after the company reported higher earnings and profit for the first quarter, boosted by growing ...

Dividend of CHF 0.24 per share approved by shareholders at the Annual General Meeting on May 8, 2024 GENEVA-- ( BUSINESS WIRE ...